semaglutide mechanism of action weight loss Tirzepatide vs for Loss: Which Drug Delivers Better Results? Why is Everyone Talking About

Clinical trials have demonstrated that AOD9604 exhibits a placebolike safety profile in obese adults, making it a welltolerated option for metabolic support [3]

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

At week 24, the Phase 2 trial recorded an average weight loss of 17.3%, with the 12mg group reaching 19.5%

K., Lingvay, I., Macura, S.,

Naruse, 2019)

While VSG has become a popular bariatric surgery due to its effectiveness in promoting initial weight loss, its not uncommon for patients to experience some degree of weight regain in the years following surgery